Innoviva, Inc. (INVA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch INVA
See up to 3 months of INVA. The 7-day demo opens the 1M and 3M ranges and puts INVA on your watchlist.
Start 7-day demoLatest INVA insider trades
Marianne Zhen - OfficerTax withholding / forfeiture$24K- Stephen Basso - OfficerTax withholding / forfeiture$12K
- Pavel Raifeld - Officer
About Innoviva, Inc. (INVA)
Innoviva, Inc. files with the SEC under CIK 0001080014 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
INVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 3 | 2,815 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
INVA insider transactions (Form 4)
4930 Form 4 filings on record, the earliest from Nov 22, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 1,127 footnote F1 | $21.00 | $24K | |
| ||||||
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 558 footnote F1 | $21.00 | $12K | |
| ||||||
| Pavel Raifeld - Officer | Tax withholding / forfeiture | Common Stock | 1,130 footnote F1 | $21.00 | $24K | |
| ||||||
| Stephen Basso - Officer | Grant or award | Common Stock | 1,123 footnote F1 | $0.00 | - | |
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 559 footnote F2 | $22.24 | $12K | |
| ||||||
| Pavel Raifeld - Officer | Grant or award | Common Stock | 1,123 footnote F1 | $0.00 | - | |
| Pavel Raifeld - Officer | Tax withholding / forfeiture | Common Stock | 1,130 footnote F2 | $22.24 | $25K | |
| ||||||
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 1,127 footnote F1 | $22.24 | $25K | |
| ||||||
| Josephine Linden | Grant or award | Common Stock | 5,733 footnote F1,F2 | $0.00 | - | |
| Josephine Linden | Grant or award | Common Stock | 9,461 footnote F1,F3 | $0.00 | - | |
| Josephine Linden | Grant or award | Non-statutory Stock Option | 9,166 | $0.00 | - | |
| ||||||
| Mark Dipaolo | Grant or award | Common Stock | 9,786 footnote F1 | $0.00 | - | |
| Mark Dipaolo | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| ||||||
| Pavel Raifeld - Officer | Grant or award | Common Stock | 126,646 footnote F1,F2 | $0.00 | - | |
| Pavel Raifeld - Officer | Grant or award | Non-statutory Stock Option | 312,500 | $0.00 | - | |
| ||||||
| Marianne Zhen - Officer | Grant or award | Common Stock | 12,766 footnote F1,F2 | $0.00 | - | |
| Marianne Zhen - Officer | Grant or award | Non-statutory Stock Option | 31,500 | $0.00 | - | |
| ||||||
 Sarah J. Schlesinger | Grant or award | Common Stock | 9,786 footnote F1 | $0.00 | - | |
| Sarah J. Schlesinger | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| ||||||
| Stephen Basso - Officer | Grant or award | Common Stock | 37,994 footnote F1,F2 | $0.00 | - | |
| Stephen Basso - Officer | Grant or award | Non-statutory Stock Option | 93,750 | $0.00 | - | |
| ||||||
| Derek A. Small | Grant or award | Common Stock | 9,786 footnote F1 | $0.00 | - | |
| Derek A. Small | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| ||||||
| Jules Haimovitz | Grant or award | Common Stock | 9,786 footnote F1 | $0.00 | - | |
| Jules Haimovitz | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| ||||||
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 1,244 footnote F1 | $23.39 | $29K | |
| ||||||
| Pavel Raifeld - Officer | Tax withholding / forfeiture | Common Stock | 2,986 | $23.39 | $70K | |
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 2,460 footnote F1 | $23.39 | $58K | |
| ||||||
| Stephen Basso - Officer | Grant or award | Common Stock | 604 footnote F1 | $0.00 | - | |
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 237 footnote F2 | $21.16 | $5K | |
| ||||||
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 992 footnote F1 | $21.16 | $21K | |
| ||||||
| Stephen Basso - Officer | Grant or award | Common Stock | 27,609 | $18.11 | $500K | |
| Pavel Raifeld - 10% Owner | Grant or award | Common Stock | 1,860 | $0.00 | - | |
| Pavel Raifeld - 10% Owner | Grant or award | Common Stock | 110,436 | $18.11 | $2.00M | |
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 991 | $19.95 | $20K | |
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 237 | $19.95 | $5K | |
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 992 | $18.78 | $19K | |
| Stephen Basso - Officer | Grant or award | Common Stock | 1,353 | $0.00 | - | |
| Stephen Basso - Officer | Tax withholding / forfeiture | Common Stock | 237 | $18.78 | $4K | |
| Derek A. Small - Director | Grant or award | Common Stock | 12,077 | $0.00 | - | |
| Derek A. Small - Director | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| Mark Dipaolo - Director | Grant or award | Common Stock | 12,077 | $0.00 | - | |
| Mark Dipaolo - Director | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| Sarah J. Schlesinger - Director | Grant or award | Common Stock | 12,077 | $0.00 | - | |
| Sarah J. Schlesinger - Director | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| Jules Haimovitz - Director | Grant or award | Common Stock | 12,077 | $0.00 | - | |
| Jules Haimovitz - Director | Grant or award | Non-statutory Stock Option | 10,000 | $0.00 | - | |
| Marianne Zhen - Officer | Grant or award | Common Stock | 300 | $0.00 | - | |
| Marianne Zhen - Officer | Tax withholding / forfeiture | Common Stock | 976 | $19.15 | $19K | |
Item 2.02, 9.01
Item 5.02, 9.01
Item 2.02, 9.01
Item 5.07
INVA insider trading FAQ
What is the latest insider trade for INVA?
Innoviva, Inc. (INVA) had 3 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for INVA runs to 30 Form 4 filings, the earliest from 2024-11-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INVA stock?
No insider purchases of INVA were filed in the last 90 days.
How many insiders are selling INVA stock?
No insider sales of INVA were filed in the last 90 days.
Where can I see INVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Marianne Zhen view on EDGAR
- - Stephen Basso view on EDGAR
- - Pavel Raifeld view on EDGAR
- - Stephen Basso view on EDGAR
- - Pavel Raifeld view on EDGAR
- - Marianne Zhen view on EDGAR
- - Josephine Linden view on EDGAR
- - Mark Dipaolo view on EDGAR
- - Pavel Raifeld view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INVA with a 7-day demo
- INVA on your watchlist
- Every INVA Form 4 filing on record
- Up to 3 months of INVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
